Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Contract Pharma | Page 10 of 281 | Pharmaceutical Outsourcing and CDMO News

What are you searching for?

Sign in

Top Stories

Online Exclusives

Inside CPHI Milan’s New Sustainability Summit

Silvia Forroova shares how CPHI Milan’s new Sustainability Summit will bring pharma leaders together to tackle key sustainability challenges.

By: Charlie Sternberg

Breaking News

Contract Pharma Announces New Bio Outsourcing Conference in Cambridge

Two-day event will bring the biopharma outsourcing community together April 1-2, 2027.

By: Tim Wright

Features

High Concentration Large Molecules for Subcutaneous Delivery

Formulation, manufacturing and delivery strategies for high-dose biologics administered subcutaneously.

By: Jim Huang, Shaukat Ali

Features

Inside the Changing HPAPI Manufacturing Landscape

Highly potent compounds are reshaping CDMO expectations, from early risk assessment to closed, automated containment facilities.

By: Charlie Sternberg

Features

From Clinical Success to Commercial Readiness: Preparing Emerging Modalities for Launch

Serialization planning, data visibility and partner connectivity can help biopharma companies prepare complex therapies for commercial scale.

By: Joe Lipari

Breaking News

VIEW ALL
Editor’s Picks

Breaking News

Contract Pharma Announces New Bio Outsourcing Conference in Cambridge

Breaking News

Lilly Breaks Ground on $6.5B Houston Manufacturing Site

Online Exclusives

CDMO Capacity: Stainless by Volume, Single-Use by Number

Features

Inside the Changing HPAPI Manufacturing Landscape
VIEW ALL

Online Exclusives

Online Exclusives

Inside CPHI Milan’s New Sustainability Summit

Silvia Forroova shares how CPHI Milan’s new Sustainability Summit will bring pharma leaders together to tackle key sustainability challenges.

By: Charlie Sternberg

Online Exclusives

Addressing Barriers to Access for Today’s Cell and Gene Therapies

Decisions around trial design, regulatory strategy, and manufacturing planning ultimately determine whether a therapy reaches patients.

By: Kristin Brooks

Online Exclusives

CDMO Capacity: Stainless by Volume, Single-Use by Number

Large stainless-steel projects are rising, but pipeline demand is increasingly moving toward smaller, more flexible manufacturing models.

By: Dan Stanton

VIEW ALL

Free eNewsletter

Subscribe to Magazine for top news, trends & analysis

Contract Services Directory

Browse companies involved in pharmaceutical manufacturing and services.

Biologics Manufacturing

VIEW ALL

505(b)(2)

VIEW ALL

Accelerated Stability Studies

VIEW ALL

Aerosol Filling

VIEW ALL
Start Searching

VideoBites

VideoBites

From Clinical Trials to Cold Chain in APAC and Beyond

Soobin Han, Customer Service Supervisor, APAC at Marken, UPS Healthcare Precision Logistics, discusses how a recent increase in clinical trial starts across the APAC region is impacting shipping worldwide, from cold chain capabilities to direct-to-patient delivery.

Released By Marken, UPS Healthcare Precision Logistics

VideoBites

Reducing Risk in Pharma Product Transfers

Aaron Dely, VP of R&D at PLD Pharma Services, discusses how in-house R&D and analytical support, ANDA strategy, and formulation experience can help pharma companies manage product transfers and avoid costly delays.

Released By PLD Pharma Services

Evotec at CPHI

VideoBites

Flexible Innovation for Complex Molecules

Evotec team shares insight on addressing solubility and bioavailability challenges for today’s complex molecules.

Released By EVOTEC

VIEW ALL

Top 20 Pharma and BioPharma Companies

VIEW ALL

October/November 2026

Current Issue

FEATURES

Pharma Matters Q&A

Pharma Matters Q&A

De-Risking Early Clinical Development

IQVIA leaders discuss trial continuity, regulatory strategy, and data-driven approaches to early clinical development.

Released By IQVIA

Pharma Matters Q&A

From Phase 3 to Commercialization: What Sponsors Need from a Sterile Injectable CDMO

August Bioservices’ Ryan Downey discusses fill-finish capacity, Annex 1 readiness, technical expertise and the infrastructure needed to move injectable programs toward commercial launch.

Released By August Bioservices

Pharma Matters Q&A

Engineering a Flawless Scale-Up: How CDMOs De-Risk the Path to Commercial Supply

Aligning manufacturing capacity with long-term client goals ensures products transition smoothly with consistent performance.

Released By Grand River Aseptic Manufacturing

VIEW ALL

Webinars

Register Now
September 29, 2026
10:00 AM

Cell-Based Assays Under FDA Scrutiny: Lessons from Recent CRLs

Sponsored By Solvias

Read more
Register now
September 17, 2026
11:00 AM

Clinical Supply Chain: The Backbone of Successful Integrated CRO-CDMO Programs

Sponsored By Thermo Fisher Scientific Pharma Services

Read more
Register Now
August 27, 2026
11:00 AM

Optimizing Plasmid Manufacturing for Cell and Gene Therapy

Sponsored By ProBio CDMO

Read more

Events

VIEW ALL

Podcasts

Pharma Matters

Setting the Stage for Success: Building Regulatory and Operational Readiness Through Strategic Planning

Where organizations most commonly encounter challenges in decision-making, and how strategic planning can help preserve their flexibility as programs mature.

Released By Cryoport Systems

Pharma Matters

Expanding for What Comes Next

Vetter’s Carsten Press discusses the strategy behind the company’s global investments and what they mean for injectable drug customers.

Released By Vetter Pharma International

combination product testing

Pharma Matters

Tackling Combination Products’ Complexity and Testing Challenges

How sponsors can navigate sterility, microbiology, E&L, and regulatory expectations as combination products become more complex.

Released By Nelson Laboratories, LLC

VIEW ALL

Expert’s Opinion

Expert’s Opinion

Design-Led Cleanrooms: How Risk-Based Digital Strategies are Reshaping Pharma

QbD, digital platforms, and risk-based, paperless validation approaches can dramatically accelerate project delivery, reduce inspection findings, and improve documentation efficiency.

By: Sachin Maled

Expert’s Opinion

From Potential to Practical at DIA 2026: Structure Before AI

What It takes to turn patient experience data into reliable, predictive insight.

By: Lindsay Hughes

Expert’s Opinion

From Potential to Practical at DIA 2026: A Three-Part Series on Unlocking AI’s Role in Modern Clinical Trials

Reimagining trial design from static protocols to predictive simulation.

By: Raja Shankar

VIEW ALL

Financial News

Emergent

Financial News

Emergent BioSolutions Restructures

Includes eliminating approximately 90 roles in an effort to improve overall cost structure and drive efficiencies.

By: Kristin Brooks

Financial News

Lilly 2Q Revenues Top $23B

Mounjaro and Zepbound drive growth in the quarter.

By: Kristin Brooks

Financial News

BeOne Medicines Plans $300M NJ Expansion, Bringing US Manufacturing Investment Over $1B

The expansion increases BeOne’s production capacity and should add about 120 new full-time jobs.

By: Patrick Lavery

VIEW ALL

Solution Content Center

companies-component-bg
Adare Pharma Solutions
View Profile
companies-component-bg
Solvias
View Profile
companies-component-bg
IDT Biologika
View Profile
companies-component-bg
Praxis Packaging Solutions
View Profile
Start Searching

Analyze This

Analyze This

A Novel Stream Sampler for Flowing Pharmaceutical Powder Mixtures

Dr. Rodolfo Romañach and Dr. Rafael Méndez from the University of Puerto Rico, Mayagüez, present a stream sampler for real-time monitoring of powder blends.

Analyze This

A New Approach to Particle Morphology

The particle size of the API and excipients affects more than just the stability and appearance of the product.

Analyze This

Generating an Equation for Process Analysis/Control

It’s not your Mom’s way, anymore.

By: Emil W. Ciurczak

VIEW ALL